VEGF-A Related SNPs: a Cardiovascular Context

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2023 Jun 8

PMID 37288254

Authors

J C Meza-Alvarado

R A Page

B Mallard

C Bromhead

B R Palmer

Affiliations

Soon will be listed here.

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Currently, cardiovascular disease risk algorithms play a role in primary prevention. However, this is complicated by a lack of powerfully predictive biomarkers that could be observed in individuals before the onset of overt symptoms. A key potential biomarker for heart disease is the vascular endothelial growth factor (VEGF-A), a molecule that plays a pivotal role in blood vessel formation. This molecule has a complex biological role in the cardiovascular system due to the processes it influences, and its production is impacted by various CVD risk factors. Research in different populations has shown single nucleotide polymorphisms (SNPs) may affect circulating VEGF-A plasma levels, with some variants associated with the development of CVDs, as well as CVD risk factors. This minireview aims to give an overview of the VEGF family, and of the SNPs reported to influence VEGF-A levels, cardiovascular disease, and other risk factors used in CVD risk assessments.

Citing Articles

The VEGFA rs2010963 Gene Polymorphism Is a Potential Genetic Risk Factor for Myocardial Infarction in Slovenian Subjects with Type 2 Diabetes Mellitus.

Grbic E, Letonja J, Petrovic D Biomolecules. 2025; 14(12.

PMID: 39766291 PMC: 11674656. DOI: 10.3390/biom14121584.

Exposure to emissions generated by 3-dimensional printing with polycarbonate: effects on peripheral vascular function, cardiac vascular morphology and expression of markers of oxidative stress in male rat cardiac tissue.

Krajnak K, Farcas M, Richardson D, Hammer M, Waugh S, McKinney W J Toxicol Environ Health A. 2024; 87(13):541-559.

PMID: 38682597 PMC: 11625379. DOI: 10.1080/15287394.2024.2346938.

Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature.

Li L, Sun W, Lv X, Xu Y, Hu Y, Shi J Front Cardiovasc Med. 2024; 10:1133662.

PMID: 38274318 PMC: 10808470. DOI: 10.3389/fcvm.2023.1133662.

References

Yun H, Noh N, Lee E . Genetic risk scores used in cardiovascular disease prediction models: a systematic review. Rev Cardiovasc Med. 2022; 23(1):8. DOI: 10.31083/j.rcm2301008. View

Rotter J, Lin H . An Outbreak of Polygenic Scores for Coronary Artery Disease. J Am Coll Cardiol. 2020; 75(22):2781-2784. PMC: 7263807. DOI: 10.1016/j.jacc.2020.04.054. View

Bridgett S, Dellett M, Simpson D . RNA-Sequencing data supports the existence of novel VEGFA splicing events but not of VEGFAb isoforms. Sci Rep. 2017; 7(1):58. PMC: 5427905. DOI: 10.1038/s41598-017-00100-3. View

Roberts R . Genetics-Current and Future Role in the Prevention and Management of Coronary Artery Disease. Curr Atheroscler Rep. 2016; 18(12):78. DOI: 10.1007/s11883-016-0628-8. View

Ma W, Wang Y, Han X, Zhu Y, Liu N . Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis. BMC Med Genet. 2018; 19(1):108. PMC: 6031176. DOI: 10.1186/s12881-018-0628-3. View

Apte R, Chen D, Ferrara N . VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019; 176(6):1248-1264. PMC: 6410740. DOI: 10.1016/j.cell.2019.01.021. View

Holmes D, Zachary I . The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005; 6(2):209. PMC: 551528. DOI: 10.1186/gb-2005-6-2-209. View

Shibuya M . Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2012; 153(1):13-9. PMC: 3528006. DOI: 10.1093/jb/mvs136. View

Cui Q, Li Y, Duan C, Zhang W, Guo X . Further evidence for the contribution of the vascular endothelial growth factor gene in coronary artery disease susceptibility. Gene. 2013; 521(2):217-21. DOI: 10.1016/j.gene.2013.03.091. View

10.

Ruotsalainen S, Partanen J, Cichonska A, Lin J, Benner C, Surakka I . An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease. Eur J Hum Genet. 2020; 29(2):309-324. PMC: 7868371. DOI: 10.1038/s41431-020-00730-8. View

11.

Connolly D, Heuvelman D, Nelson R, Olander J, Eppley B, Delfino J . Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989; 84(5):1470-8. PMC: 304011. DOI: 10.1172/JCI114322. View

12.

Knowles J, Ashley E . Cardiovascular disease: The rise of the genetic risk score. PLoS Med. 2018; 15(3):e1002546. PMC: 5877829. DOI: 10.1371/journal.pmed.1002546. View

13.

Totomoch-Serra A, Munoz M, Burgueno J, Revilla-Monsalve M, Diaz-Badillo A . Association of common polymorphisms in the and genes with type 2 diabetes-related traits in Mexicans. Arch Med Sci. 2018; 14(6):1361-1373. PMC: 6209716. DOI: 10.5114/aoms.2018.74757. View

14.

Fahey E, Doyle S . IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis. Front Immunol. 2019; 10:1426. PMC: 6603210. DOI: 10.3389/fimmu.2019.01426. View

15.

Roberts R . A Breakthrough in Genetics and its Relevance to Prevention of Coronary Artery Disease in LMIC. Glob Heart. 2017; 12(3):247-257. DOI: 10.1016/j.gheart.2017.04.001. View

16.

Dong P . Association of vascular endothelial growth factor expression and polymorphisms with the risk of gestational diabetes mellitus. J Clin Lab Anal. 2018; 33(2):e22686. PMC: 6818619. DOI: 10.1002/jcla.22686. View

17.

Sun B, Maranville J, Peters J, Stacey D, Staley J, Blackshaw J . Genomic atlas of the human plasma proteome. Nature. 2018; 558(7708):73-79. PMC: 6697541. DOI: 10.1038/s41586-018-0175-2. View

18.

Merlo S, Nikolajevic Starcevic J, Mankoc S, Santl Letonja M, Cokan Vujkovac A, Zorc M . Vascular Endothelial Growth Factor Gene Polymorphism (rs2010963) and Its Receptor, Kinase Insert Domain-Containing Receptor Gene Polymorphism (rs2071559), and Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus. J Diabetes Res. 2016; 2016:1482194. PMC: 4736196. DOI: 10.1155/2016/1482194. View

19.

Buroker N . VEGFA rSNPs, transcriptional factor binding sites and human disease. J Physiol Sci. 2013; 64(1):73-6. PMC: 10717560. DOI: 10.1007/s12576-013-0293-4. View

20.

Assimes T, Roberts R . Genetics: Implications for Prevention and Management of Coronary Artery Disease. J Am Coll Cardiol. 2016; 68(25):2797-2818. DOI: 10.1016/j.jacc.2016.10.039. View